AI-powered target identification and drug positioning

We combine cutting-edge machine learning and biology to advance drug discovery

What we do

We develop state-of-the-art, AI-based computational technologies from rich, multimodal patient data to discover new treatments

Challenges

We need better drugs, better targets, and better clinical trials

Challenge 1

Targets don’t convert to drugs

  • Patient data is underutilized
  • Pre-clinical models lack translatability to human biology
  • Disease heterogeneity is not captured

Challenge 2

Drug responses vary between patients

  • Lack understanding of tumor microenvironment
  • Lack understanding of drug mechanism of action
  • Incomplete knowledge of clinical heterogeneity

Owkin's solution

AI engines to revolutionize drug discovery

Book a demo with Owkin